• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cerebrospinal fluid C9 in demyelinating disease.

作者信息

Compston D A, Morgan B P, Oleesky D, Fifield R, Campbell A K

出版信息

Neurology. 1986 Nov;36(11):1503-6. doi: 10.1212/wnl.36.11.1503.

DOI:10.1212/wnl.36.11.1503
PMID:3762967
Abstract

We measured CSF and plasma concentrations of C9, IgG, and albumin in 91 patients with demyelination and 73 controls with other neurologic diseases. The C9 index was reduced and IgG index increased in patients with multiple sclerosis and those with isolated demyelinating lesions, irrespective of disease activity; abnormalities were less marked in patients with isolated lesions than in those with MS. Humoral mechanisms may not be responsible for initiating demyelination, but activation of the complement system could amplify tissue damage and account for some symptomatic recovery.

摘要

相似文献

1
Cerebrospinal fluid C9 in demyelinating disease.
Neurology. 1986 Nov;36(11):1503-6. doi: 10.1212/wnl.36.11.1503.
2
Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis.多发性硬化症患者脑脊液中的补体终末成分(C9)
Lancet. 1984 Aug 4;2(8397):251-4. doi: 10.1016/s0140-6736(84)90298-8.
3
Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls.多发性硬化症患者和神经学对照者脑脊液中的补体终末成分(C9)
Neurology. 1990 May;40(5):855-7. doi: 10.1212/wnl.40.5.855.
4
Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis.
Acta Neurol Scand. 1989 Aug;80(2):130-5. doi: 10.1111/j.1600-0404.1989.tb03854.x.
5
Elevation of human cerebrospinal fluid clusterin concentration is associated with acute neuropathology.人类脑脊液中聚集素浓度升高与急性神经病理学相关。
J Neurol Sci. 1993 Apr;115(2):230-3. doi: 10.1016/0022-510x(93)90230-v.
6
The cerebrospinal fluid proteins in multiple sclerosis.
Clin Lab Med. 1986 Sep;6(3):457-75.
7
Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.脑脊液分析可区分复发缓解型多发性硬化症和继发进展型多发性硬化症。
J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):446-51. doi: 10.1136/jnnp.63.4.446.
8
Cerebrospinal fluid and neuropathological study in Devic's syndrome. Evidence of intrathecal immune activation.
J Neurol Sci. 1987 Dec;82(1-3):281-90. doi: 10.1016/0022-510x(87)90024-4.
9
Cerebrospinal fluid immunoglobulin G in childhood. Measurement by electroimmunodiffusion.儿童脑脊液免疫球蛋白G。用电免疫扩散法进行测定。
Arch Neurol. 1971 May;24(5):441-8. doi: 10.1001/archneur.1971.00480350075008.
10
A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications.一项使用等电聚焦和Log IgG指数对1007例疑似神经系统疾病患者脑脊液中免疫球蛋白G的研究。比较与诊断应用。
Brain. 1990 Oct;113 ( Pt 5):1269-89. doi: 10.1093/brain/113.5.1269.

引用本文的文献

1
Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders.免费补体和包含补体的细胞外囊泡作为神经炎症和神经退行性疾病的潜在生物标志物。
Front Immunol. 2023 Jan 20;13:1055050. doi: 10.3389/fimmu.2022.1055050. eCollection 2022.
2
Plasma Protein Levels Analysis in Multiple Sclerosis Sardinian Families Identified C9 and CYP24A1 as Candidate Biomarkers.对撒丁岛多发性硬化症家族的血浆蛋白水平分析确定C9和CYP24A1为候选生物标志物。
Life (Basel). 2022 Jan 20;12(2):151. doi: 10.3390/life12020151.
3
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
多发性硬化斑块中的补体激活:免疫组织化学分析。
Acta Neuropathol Commun. 2014 May 9;2:53. doi: 10.1186/2051-5960-2-53.
4
Systemic complement profiling in multiple sclerosis as a biomarker of disease state.多发性硬化症中系统性补体谱作为疾病状态的生物标志物。
Mult Scler. 2012 Oct;18(10):1401-11. doi: 10.1177/1352458512438238. Epub 2012 Feb 21.
5
Complement in multiple sclerosis: its role in disease and potential as a biomarker.补体在多发性硬化症中的作用:其在疾病中的角色及作为生物标志物的潜力
Clin Exp Immunol. 2009 Feb;155(2):128-39. doi: 10.1111/j.1365-2249.2008.03830.x. Epub 2008 Nov 24.
6
Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.中枢神经系统中脱髓鞘和髓鞘再生的效应器:对多发性硬化症的影响
Brain Pathol. 2007 Apr;17(2):219-29. doi: 10.1111/j.1750-3639.2007.00065.x.
7
The complement system in central nervous system diseases.中枢神经系统疾病中的补体系统。
Immunol Res. 2001;24(1):79-86. doi: 10.1385/IR:24:1:79.
8
Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders.
J Neurol. 1994 Aug;241(9):557-60. doi: 10.1007/BF00873519.
9
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results.高剂量甲基强的松龙治疗多发性硬化症患者的双盲对照试验:2.实验室结果
J Neurol Neurosurg Psychiatry. 1987 May;50(5):517-22. doi: 10.1136/jnnp.50.5.517.
10
Reversible injury of cultured rat oligodendrocytes by complement.补体对培养的大鼠少突胶质细胞的可逆性损伤
Immunology. 1989 Aug;67(4):441-6.